[Indicators of cognitive impairment of varying severity in the acute period of ischemic stroke].

Objective: To assess phenotype and identify biomarkers of cognitive impairment (CI) of varying severity in patients in the acute period of ischemic stroke (IS) based on the analysis of clinical and paraclinical indicators.

Material And Methods: Two hundred and forty patients with diagnosed IS and presence of CI were examined. Depending on the scores on the Montreal Cognitive Assessment Scale, patients were divided into two groups: group 1 (=182) with mild CI, group 2 (=58) with dementia.